High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's disease

Leukemia and Lymphoma

Volumn 20, Issue 3-4, 1996, Pages 259-266

  Fleury, Joel ^a   Legros, Michel ^a   Colombat, Philippe ^b   Cure, Herve ^a   Travade, Philippe ^a   Tortochaux, Jacques ^a   Dionet, Claude ^a   Chollet, Philippe ^a   Linassier, Claude ^b   Lamagnere, Jean Pierre ^b   Blaise, Didier ^c   Viens, Patrice ^c   Maraninchi, Dominique ^c   Plagne, Robert ^a  

^a CENTRE JEAN PERRIN   (France)

^b CHU BRETONNEAU   (France)

^c INSTITUT PAOLI CALMETTES   (France)

Author keywords

Autologous bone marrow transplantation; Hodgkin

Indexed keywords

BLEOMYCIN; CARMUSTINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW RESCUE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029617251     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609051616     Document Type: Article

References (16)

1. De Vita, V. T. Jr. and Serpick, A. (1967) Combination chemotherapy in the treatment of advanced Hodgkin's disease. Proc. Am. Assoc. Cancer Res., 8, 13 (abstract).
2. De Vita, V. T., Carbone, P. P. and Serpick, A. A. (1970) Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann. Intern. Med., 73, 881.
3. Bonnadona, G., Santoro, A., Bonfante, V. et al. (1982) Cyclic delivery of MOPP and ABVD combinations and stage IV Hodgkin's disease: rational, background studies and recent results. Cancer Treat. Rep., 66, 881-887.
4. Bonnadona, G., Valagussa, P. and Santoro, A. (1986) Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8 years results. Ann. Intern. Med., 104, 739-746.
5. Gobbi, P. G., Cavalli, C., Gendarini, A. et al. (1985) Reevaluation of prognostic significance of symptoms in Hodgkin's disease. Cancer, 56, 2874-2880.
6. Mauch, P., Gorshein, D., Cunnincham, J. et al. (1982) Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease. Cancer Treat. Rep., 66, 809-817.
7. Straus, D. J. P., Gaynor, J. J., Miers, J. et al. (1990) Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy. J. Clin. Oncol., 8, 1173-1186.
8. Auclerc, G., Auclerc, M. F., Weil, M. et al. (1979) Features and prognosis of chemotherapy treated Hodgkin's disease with initial bone marrow involvement. Cancer Chemother. Pharmacol., 2, 189-196.
9. Wasgstaff, J., Gregory, W. M., Swindell, R. et al. (1988) Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centers. Br. J. Cancer, 58, 487-492.
10. Specht, L. and Nissen, N. I. (1988) Prognostic factors in Hodgkin's disease stage IV. Eur. J. Haematol., 41, 359-367.
11. Löffler, M., Dixon, D. O. and Swindell, R. (1990) Prognostic factors of stage III and IV Hodgkin's disease. In Treatment strategy in Hodgkin's disease. Colloque INSERM/Libbey, vol 196, edited by R. Somers, M. Henry-Amar, J. H. Meerwaldt, P. Carde, pp. 89-103. Eurotext Ltd.
12. Proctor, S. J., Taylor, P., Donnan, P., Boys, R., Lennard, A. and Prescott, R. J. with members of the Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party (1991) A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. Eur. J. Cancer, 27, 624-629.
13. Carella, A.M., Carlier, P., Couvin, A. et al. (1991) Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol. Bone Marrow Transplant., 8, 99-103.
14. Fleury, J., Legros, M., Colombat, P. et al. (1993) High dose chemotherapy with autologous stem cell transplantation as consolidation therapy for stage IV Hodgkin's disease with poor prognosis factors. A multiinstitutional pilot trial. Proc. Am. Soc. Clin. Oncol., 12, 374, abstract 1270.
15. Carbone, P. P., Kaplan, H. S., Musshof, et al. (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Res., 31, 1860-1861.
16. Lukes, R. J., Butler, J. J. and Hicks, E. B. (1966) Natural history of Hodgkin's disease as related to its pathologic picture. Cancer, 19, 317-344.